Factors Associated With Thickness of Fascia in Patients With Type 2 Diabetes: A cross-sectional study

Factors Associated With Thickness of Fascia in Patients With Type 2 Diabetes: A cross-sectional study - Factors Associated With Thickness of Fascia in Patients With Type 2 Diabetes: A cross-sectional study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051790

Enrollment

Registered

2024-01-01

Start date

2023-11-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Outpatients with type 2 diabetes at the research institution 2.Age between 40 and 75 3.Persons who have consented in writing (excluding proxy consenters)

Exclusion criteria

Exclusion criteria: 1.Athletes, bodybuilders 2.History of the following: Charcot joint, congenital or acquired ankle deformity, plantar fasciitis, leg amputation, trauma 3.Neurological diseases other than diabetic neuropathy 4.Steroid users 5.Smoker 6.Significant restriction of movement 7.Malnutrition 8.Those who do not understand or agree with the purpose of the research 9.Persons judged inappropriate by the attending physician, Investigator, or co-investigator

Design outcomes

Primary

Measure	Time frame
thickness of myofacsia in the dominant leg (gastrocnemius)	—

Countries

Japan

Contacts

Public ContactNaoko Awane

Tokyo Medical University Hachioji Medical Center Department of Diabetology,Endocrinology,and Metabolism

dmnaika@tokyo-med.ac.jp042-665-5611

Outcome results